Irinotecan is inactive as a first-line treatment, but plays an important part in gastric cancer treatment
Hiroya TakiuchiVolume:
14
Language:
english
Pages:
3
DOI:
10.1007/s10120-011-0018-4
Date:
March, 2011
File:
PDF, 103 KB
english, 2011